Arcadia Biosciences

Arcadia Biosciences, Inc. is an agricultural biotechnology company, which engages in the development of agricultural products. It uses screening, breeding, and biotechnology techniques to create agricultural products for consumers, processors, and farmers. Its products include GoodWheat pasta, Zola coconut water, ProVault topical pain relief, and SoulSpring bath and body care. The company was founded by Eric J. Rey and John G. Sperling in 2002 and is headquartered in Davis, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Arcadia Biosciences reports positive Q1 results, eyes revenue growth

Arcadia Biosciences delivered strong financial performance in Q1 2024, driven by revenue growth and cost management. The company faces challenges in retail execution but has opportunities for revenue growth through brand expansions and strategic partnerships.

Arcadia Biosciences reports strong Q2 driven by Zola growth

Arcadia Biosciences delivered solid financial performance in Q2 2024 driven by Zola Coconut Water.
Efficient cost-saving measures and strategic asset monetization bolstered profitability.
Challenges include managing increased costs and sustaining growth momentum.
Opportunities lie in expanding Zola brand, diversifying revenue streams, and strategic partnerships.

Arcadia Biosciences reports robust Q3 revenue growth driven by Zola

Arcadia Biosciences delivered strong revenue growth, particularly driven by Zola coconut water sales. Despite challenges in providing forward guidance, the company remains optimistic about Zola's performance and is focused on cost reduction and new product development to drive future growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Arcadia Biosciences, Inc. is an agricultural biotechnology company, which engages in the development of agricultural products. It uses screening, breeding, and biotechnology techniques to create agricultural products for consumers, processors, and farmers. Its products include GoodWheat pasta, Zola coconut water, ProVault topical pain relief, and SoulSpring bath and body care. The company was founded by Eric J. Rey and John G. Sperling in 2002 and is headquartered in Dallas, TX.

Arcadia Biosciences, Inc. (RKDA) CEO Matt Plavan on Q3 2019 Results - Earnings Call Transcript

Arcadia Biosciences, Inc. (NASDAQ: RKDA) reported third-quarter revenue of $392,000 on Wednesday, an increase from revenue of $370,000 in the same quarter in 2018.

Arcadia Biosciences Falls On Quarterly Net Loss of $14.2M, CEO Says Hemp Research 'More Valuable Than Ever'

Preview Of Q3 For Arcadia Biosciences

Arcadia Biosciences, Inc. (NASDAQ: RKDA) released Tuesday an update on its joint venture with Legacy Ventures Hawaii, Archipelago™ Ventures.

Arcadia Biosciences Updates Joint Venture With Archipelago Ventures

USDA approval of soybean could be a major catalyst longer term for RKDA, potentially generating up to $125M in annual revenues at 60%+ margins.

Arcadia Biosciences: Trading At Cash With Several Near-Term Catalysts

Arcadia Specialty Genomics, a hemp-focused operating unit of crop innovation company Arcadia Biosciences Inc (NASDAQ: RKDA), announced this week plans for a new sun-grown hemp cultivation and agronomic research facility in Imperial County, California.

A Subsidiary Of Arcadia Bio Received A New Hemp License In California

Shares of agricultural biotech company Arcadia Biosciences Inc. shot up 35% on Monday after the company said it expects total revenues in 2020 and 2021 to exceed $10 million and $30 million, respectively.

Arcadia stock rockets 35% after company issues bullish guidance for 2020 and 2021

Agricultural biotechnology company Arcadia Biosciences, Inc. (NASDAQ: RKDA) announced Monday that it has signed a binding term sheet agreement with Arista Cereal Technologies and Bay State Milling Company for the commercialization of its high-fiber wheat.

Arcadia Biosciences Rallies After Announcing Financial Guidance, Partnerships To Market High-Fiber Wheat

Arcadia Biosciences, Inc. (RKDA) CEO Rajendra Ketkar on Q2 2019 Results - Earnings Call Transcript

Arcadia Biosciences (NASDAQ: RKDA) is expected to announce Tuesday a joint venture with Legacy Ventures Hawaii to grow, extract and sell superior hemp products, Benzinga has learned exclusively.

Scoop: Arcadia Biosciences Announces Joint Venture For Hemp Project In Hawaii

Arcadia Biosciences (RKDA) delivered earnings and revenue surprises of -103.28% and -60.50%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

Arcadia Biosciences (RKDA) Reports Q1 Loss, Misses Revenue Estimates

Arcadia Biosciences' (RKDA) CEO Rajendra Ketkar on Q1 2019 Results - Earnings Call Transcript

Arcadia Biosciences (RKDA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Arcadia Biosciences (RKDA) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Arcadia Biosciences, Inc. (RKDA) CEO Rajendra Ketkar on Q4 2018 Results - Earnings Call Transcript

In July of last year I explained why I wanted to have exposure to the agricultural genome-editing space, and after examining a few pure plays, I then went on to describe why Arcadia Biosciences was my favorite -- though speculative -- choice.

Arcadia Biosciences Entry Into The Cannabis Space Creates Substantial Value

News for Arcadia Biosciences Stock (RKDA)